2. #ESOPEC: Ph III, periop FLOT vs NeoAdj Chemoradiation in adeno esophageal Ca:

- pCR ⬆️ FLOT (17% vs 10%). Much ⬇️ pCR than original CROSS (23%)

- 3 yr OS: 57.4% vs 50.7% (mOS: 66mos vs 37mos)

3/8

#GI25 highlights #CommunityOnc:

1. #SCIENCE: Adv Eso SCC

2. #ESOPEC publication (Eso/GEJ/Ga)

3. Chemo in resectable Panc Ca

4. #StarterNET: GEP-NET

5. #CM8HW: dMMR/MSI-H mCRC

6. #BREAKWATER: BRAFV600E mCRC

7. ctDNA: #BESPOKE + SWOG80702

#OncSky #gism @ascocancer.bsky.social

1/8

So much excited data shared on Day 1️⃣ of #GI25 from #biomarker 🎯 testing in #esocsm #stcsm to the role of #RT in #esocsm in light 💡 of #ESOPEC. Excited for more great science and discovery on Day 2️⃣!